Analysen des hämatopoetischen Chimärismus - TOBIAS-lib ...

(42) Gardiner N, Lawler M, O'Riordan JM, Duggan C, De Arce M, McCann SR.
Monitoring of lineage-specific chimaerism allows early prediction of
response following donor lymphocyte infusions for relapsed chronic
myeloid leukaemia. Bone Marrow Transplant 1998; 21(7):711-719.
(43) Gardiner N, McCann SR, O'Riordan J, Lawler M. Chimerism following
donor lymphocyte infusion for chronic myeloid leukemia. Blood 1999;
93(8):2748-2749.
(44) Gorczynska E, Turkiewicz D, Toporski J, Kalwak K, Rybka B, Ryczan R,
Sajewicz L, Chybicka A. Prompt initiation of immunotherapy in children
with an increasing number of autologous cells after allogeneic HCT can
induce donor-type chimerism: a report of 14 children. Bone Marrow
Transplant 2004; 33:211-217.
(45) Gratwohl A. Entwicklung der hämatopoetischen Vorläuferzell-
Transplantation. In: Bartsch HH, Mertelsmann R, editors. Knochenmark
und periphere Stammzelltransplantation. Freiburg: 1996.
(46) Hancock JP, Burgess MF, Goulden NJ, Steward CG, Knechtli CJ,
Pamphilon DH, Potter MN, Oakhill A. Same-day determination of
chimaeric status in the immediate period following allogeneic bone marrow
transplantation. Br J Haematol 1997; 99(2):403-409.
(47) Hebart H, Einsele H. Infektiöse Komplikationen nach autologer und
allogener Stammzelltransplantation. In: Bartsch HH MR, editor.
Knochenmark- und periphere Stammzelltransplantation. Freiburg: 1996:
16-24.
(48) Hoelzer D, Gokbuget N, Ottmann O, Pui CH, Relling MV, Appelbaum FR,
van Dongen JJ, Szczepanski T. Acute lymphoblastic leukemia.
Hematology (Am Soc Hematol Educ Program ) 2002; 162-92:-92.
(49) Jacobsen LO. Effekt of spleen protection on mortality following xirradiation.
J lab clin med 1949.
(50) Keil F, Haas O, Fritsch G, Kalhs G, Lechner K, Mannhalter C, Reiter E,
Niederwieser D, Hoecker P, Greinix HT. Donor lymphozyt infusions for
leukemic relapse after allogenic marrow translpantation: lack of residual
donor hematopoesis predicts aplasia. Blood 1997; 89:3113-3117.
(51) Kern W, Danhauser-Riedl S, Ratei R, Schnittinger S, Schoch G, Kolb HJ,
Ludwig WD, Hiddemann W, Haferlach T. Detection of minimal residual
disease in unselected patients with akute myeloid leukemia using
multiparameter flowcytometry to define leukemia-associated
immunophenotypes and determine their frequencies in normal bone
marrow. Haematologica 2003; 88:646-653.
80